Insulin glargine and liraglutide outperformed other type 2 diabetes drug medications in a clinical trial
The study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is part of the National Institutes of Health. Of the 37 million Americans with diabetes, approximately 90% to 95% have type 2 diabetes, according to the Centers for Disease Control and Prevention. Keeping blood sugar levels within the recommended […]